ebomi
Colour theme
Sign in
Insider · CIK 0001598754

Public Joint Stock Co Pharmstandard

CIK 0001598754 Name as filed on the most recent filing

Filed as Public Joint Stock Co Pharmstandard (14)

23 transaction lines · from 14 filings · filed 2014-02-12 to 2016-10-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-10-07 P, Open-market purchase Argos Therapeutics IncARGS 99,330, acquired Open Form 4 filing 0000904454-16-001492
2016-10-06 P, Open-market purchase Argos Therapeutics IncARGS 12,698, acquired Open Form 4 filing 0000904454-16-001492
2016-10-05 P, Open-market purchase Argos Therapeutics IncARGS 4,365, acquired Open Form 4 filing 0000904454-16-001492
2016-10-04 P, Open-market purchase Argos Therapeutics IncARGS 33,599, acquired Open Form 4 filing 0000904454-16-001492
2016-10-03 P, Open-market purchase Argos Therapeutics IncARGS 53,148, acquired Open Form 4 filing 0000904454-16-001467
2016-09-30 P, Open-market purchase Argos Therapeutics IncARGS 142,393, acquired Open Form 4 filing 0000904454-16-001467
2016-09-29 P, Open-market purchase Argos Therapeutics IncARGS 69,460, acquired Open Form 4 filing 0000904454-16-001459
2016-09-28 P, Open-market purchase Argos Therapeutics IncARGS 129,472, acquired Open Form 4 filing 0000904454-16-001459
2016-09-20 P, Open-market purchase Argos Therapeutics IncARGS 196,805, acquired Open Form 4 filing 0000904454-16-001451
2016-09-19 P, Open-market purchase Argos Therapeutics IncARGS 26,561, acquired Open Form 4 filing 0000904454-16-001451
2016-09-16 P, Open-market purchase Argos Therapeutics IncARGS 175,101, acquired Open Form 4 filing 0000904454-16-001445
2016-09-15 P, Open-market purchase Argos Therapeutics IncARGS 75,589, acquired Open Form 4 filing 0000904454-16-001445
2016-09-01 P, Open-market purchase Argos Therapeutics IncARGS 81,150, acquired Open Form 4 filing 0000904454-16-001433
2016-08-24 P, Open-market purchase Argos Therapeutics IncARGS 262,863, acquired Open Form 4 filing 0000904454-16-001386
2016-08-24 P, Open-market purchase Argos Therapeutics IncARGS 252,374, acquired Open Form 4 filing 0000904454-16-001393
2016-08-23 P, Open-market purchase Argos Therapeutics IncARGS 41,852, acquired Open Form 4 filing 0000904454-16-001386
2016-08-22 P, Open-market purchase Argos Therapeutics IncARGS 93,507, acquired Open Form 4 filing 0000904454-16-001380
2016-08-19 P, Open-market purchase Argos Therapeutics IncARGS 226,407, acquired Open Form 4 filing 0000904454-16-001380
2016-08-02 P, Open-market purchase Argos Therapeutics IncARGS Not reported Open Form 4 filing 0000899243-16-026291
2016-06-29 P, Open-market purchase Argos Therapeutics IncARGS Not reported Open Form 4 filing 0000904454-16-001302
2016-03-14 P, Open-market purchase Argos Therapeutics IncARGS Not reported Open Form 4 filing 0000904454-16-001129
2014-10-27 P, Open-market purchase Proteon Therapeutics IncPRTO 6,000,000, acquired Open Form 4 filing 0001104659-14-074940
2014-02-12 P, Open-market purchase Argos Therapeutics IncARGS 10,200,000, acquired Open Form 4 filing 0001209191-14-009833

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Public Joint Stock Co Pharmstandard, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001598754

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.